US Venture Partners X L.P., 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 20,309 shares at $1.00 ($20K) on 2022-07-20, disclosed to the SEC on 2022-07-22.
Open-market sale of $20k EFTR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 304 | $304 | 1.6% |
| 2 | $1.00 | 9,726 | $10K | 49.8% |
| 3 | $0.96 | 81 | $78 | 0.4% |
| 4 | $0.96 | 2,584 | $2K | 12.7% |
| 5 | $0.91 | 231 | $210 | 1.1% |
| 6 | $0.91 | 7,383 |
| $7K |
| 34.4% |
| Total | $0.96 avg | 20,309 | $20K | 100% |
| Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |
| EFTR | SELL | 2021-11-26 | $781K | — | Filing → |
| NARI | BUY | 2020-05-27 | $1.9M | — | Filing → |